MX9200342A - Antagonistas de hlhl. - Google Patents

Antagonistas de hlhl.

Info

Publication number
MX9200342A
MX9200342A MX9200342A MX9200342A MX9200342A MX 9200342 A MX9200342 A MX 9200342A MX 9200342 A MX9200342 A MX 9200342A MX 9200342 A MX9200342 A MX 9200342A MX 9200342 A MX9200342 A MX 9200342A
Authority
MX
Mexico
Prior art keywords
hlhl
antagonists
hlhl antagonists
Prior art date
Application number
MX9200342A
Other languages
English (en)
Inventor
Andrew V Schally
Tamas Janaky
Antilla Juhasz
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of MX9200342A publication Critical patent/MX9200342A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/11Gonadotropin; related peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/13Luteinizing hormone-releasing hormone; related peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/32Modification to prevent enzymatic degradation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MX9200342A 1991-01-30 1992-01-28 Antagonistas de hlhl. MX9200342A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/647,786 US5171835A (en) 1988-10-21 1991-01-30 LHRH antagonists

Publications (1)

Publication Number Publication Date
MX9200342A true MX9200342A (es) 1992-08-01

Family

ID=24598270

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9200342A MX9200342A (es) 1991-01-30 1992-01-28 Antagonistas de hlhl.

Country Status (13)

Country Link
US (1) US5171835A (es)
EP (1) EP0522152A1 (es)
JP (1) JPH05505630A (es)
CA (1) CA2079461A1 (es)
FI (1) FI924405A0 (es)
HU (1) HUT63635A (es)
IE (1) IE920287A1 (es)
LV (1) LV5806B4 (es)
MX (1) MX9200342A (es)
PT (1) PT100077B (es)
TW (1) TW304198B (es)
WO (1) WO1992013883A1 (es)
ZA (1) ZA92600B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429186B1 (en) 1991-05-10 2002-08-06 Genentech, Inc. Ligand antagonists for treatment of breast cancer
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
EP0683792B1 (en) * 1992-12-18 2001-09-26 Abbott Laboratories Lhrh antagonists having modified aminoacyl residues at postions 5 and 6
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
ES2180576T3 (es) * 1993-04-27 2003-02-16 United Biomedical Inc Construcciones peptidicas de lhrh inmunogenicas y estimuladores de inmunidad universales sinteticos para vacunas.
US5413990A (en) * 1993-08-06 1995-05-09 Tap Pharmaceuticals Inc. N-terminus modified analogs of LHRH
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US6048863A (en) 1994-04-19 2000-04-11 Takeda Chemical Industries, Ltd. Condensed-ring thiophene derivatives and thienopyrimidine derivatives, their production and use
EP0769956B1 (en) * 1994-07-22 2000-03-15 The Medical College Of Hampton Roads USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
DE69623655T2 (de) * 1995-10-19 2003-04-24 Takeda Chemical Industries, Ltd. Chinolinderivate als gnrh antagonisten
CN1063446C (zh) * 1995-10-19 2001-03-21 武田药品工业株式会社 作为***释放激素拮抗剂的噻吩并吡啶衍生物
US5828149A (en) * 1996-07-18 1998-10-27 Baker Hughes Incorported Lubricant inducer pump for electrical motor
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5821230A (en) * 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US5925730A (en) * 1997-04-11 1999-07-20 Ferring Bv GnRH antagonists
US6217844B1 (en) 1998-04-27 2001-04-17 Praecis Pharmaceuticals, Inc. Methods for detecting lesions in dense breast tissue using LHRH antagonists
FR2788527A1 (fr) * 1999-01-15 2000-07-21 Bio Merieux Pseudopeptide, procede de synthese, reactif et applications
US6455499B1 (en) 1999-02-23 2002-09-24 Indiana University Foundation Methods for treating disorders associated with LHRH activity
AU7627200A (en) * 1999-07-29 2001-02-19 Johns Hopkins University, The Activation of peptide prodrugs by hk2
WO2002002144A1 (en) * 2000-07-05 2002-01-10 Takeda Chemical Industries, Ltd. Medicinal preparations for treating sex hormone-dependent diseases
US6583153B2 (en) 2000-12-12 2003-06-24 Ortho-Mcneil Pharmaceutical, Inc. 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
WO2002056903A2 (en) * 2001-01-17 2002-07-25 Praecis Pharmaceuticals Inc. Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
EP1479684A4 (en) 2002-01-30 2006-01-04 Takeda Pharmaceutical THIENOPYRIMIDINES, PROCESS FOR THEIR PRODUCTION AND THEIR USE
EP1711159B1 (en) 2003-12-30 2013-03-20 Durect Corporation Solid implants containing a block copolymer for controlled release of a gnrh compound
EP2310028B1 (en) 2008-06-12 2016-11-16 Ipsen Bioinnovation Limited Fusion proteins for use in the treatment of acromegaly
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
SI3064498T1 (sl) 2013-10-30 2019-11-29 Shanghai hengrui pharmaceutical co ltd Derivati pirazolopirimidona ali pirolotriazona, postopki priprave le-teh in farmacevtske uporabe le-teh
US20220267347A1 (en) 2019-07-29 2022-08-25 Sunshine Lake Pharma Co., Ltd. Substituted pyrimidinedione compounds and uses thereof
WO2023072284A1 (zh) 2021-11-01 2023-05-04 山东绿叶制药有限公司 促性腺素释放激素拮抗剂及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963691A (en) * 1974-10-07 1976-06-15 Merck & Co., Inc. Synthetic antigens of luteinizing hormone releasing hormone
FI832053L (fi) * 1982-06-10 1983-12-11 Syntex Inc Nonapeptid- och dekapeptidanaloger av lhrh anvaendbara som lhrh-antagonister samt deras framstaellningsfoerfarande
US4565804A (en) * 1984-09-07 1986-01-21 The Salk Institute For Biological Studies GnRH Antagonists VI
US4851385A (en) * 1987-07-15 1989-07-25 Indiana University Foundation LHRH antagonist analogs having low histamine-release activity
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
EP0364819A3 (en) * 1988-10-21 1991-03-06 The Administrators of The Tulane Educational Fund Lhrh analogs
GB2228262B (en) * 1989-01-25 1992-10-07 Nat Inst Immunology Antigenic derivative of gnrh
NL8900726A (nl) * 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.

Also Published As

Publication number Publication date
ZA92600B (en) 1992-10-28
WO1992013883A1 (en) 1992-08-20
CA2079461A1 (en) 1992-07-31
LV5806B4 (lv) 1997-06-20
US5171835A (en) 1992-12-15
LV5806A4 (lv) 1997-02-20
JPH05505630A (ja) 1993-08-19
PT100077B (pt) 1999-06-30
TW304198B (es) 1997-05-01
PT100077A (pt) 1993-04-30
FI924405A (fi) 1992-09-30
EP0522152A1 (en) 1993-01-13
FI924405A0 (fi) 1992-09-30
HUT63635A (en) 1993-09-28
IE920287A1 (en) 1992-07-29
HU9202778D0 (en) 1992-12-28

Similar Documents

Publication Publication Date Title
MX9200342A (es) Antagonistas de hlhl.
DE122006000020I1 (de) Aerosolpraparate.
FI922512A0 (fi) Skyddsanordning foer sjaelvindragande underhudsnaolar.
FI921761A0 (fi) En elektrisk vinsch.
FI920235A (fi) Biaxiellt straeckt polypropylenmonofolie.
MX9202978A (es) Compuestos de amino-4-aril-tiazoles.
DE59201883D1 (de) Tilger.
FI920399A0 (fi) Fluorescerande belaeggning.
FI920564A0 (fi) Heterocykliska kvaevefoereningar.
FI923504A0 (fi) Ventilenhet.
FI923073A0 (fi) Pyrrolopyraziner.
FI921144A0 (fi) Tvaodelad ostomianordning.
FI924315A0 (fi) Servoaggregat foer fordon.
FI923438A0 (fi) Enfasig loesnings- och kausticerings- metod.
MX9202690A (es) Nuevos compuestos de cefem.
FI920296A0 (fi) Torkdelen.
DE59105384D1 (de) Anomaloskop.
FI923646A0 (fi) Vaermekaensligt uppteckningsmaterial.
FR2685617B1 (fr) Collerette perfectionnee.
FI923823A0 (fi) Foerbraenningsmotor.
FI915497A0 (fi) Golvbrunn.
FI911730A0 (fi) Centralbaserat tjuvalarmsfoerfarande.
FI915869A0 (fi) Form.
ES1016842Y (es) Carpeta-agenda.
ES1018067Y (es) Tarjeta-puzzle.